Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Sung-Soo Kim, Sojung Won, Ha Eun Lee, Seung Hyun Ryu, Dong Joon Choi, Sung Ig Cho, Byoung Joo Gwag, Hwa-Young Youn & Jin Hwan Lee. (2022) Potent Analgesic Action of 2-acetoxy-5-(2-4 (trifluoromethyl)-phenethylamino)-benzoic Acid (Flusalazine) in Experimental Mice. Journal of Pain Research 15, pages 3869-3879.
Read now
Read now
Wissam H. Faour, Mohamed Mroueh, Costatantine F. Daher, Rasha Y. Elbayaa, Hanan M. Ragab, Asser I. Ghoneim, Ahmed I. El-mallah & Hayam M. A. Ashour. (2016) Synthesis of some new amide-linked bipyrazoles and their evaluation as anti-inflammatory and analgesic agents. Journal of Enzyme Inhibition and Medicinal Chemistry 31:6, pages 1079-1094.
Read now
Read now
Nikolaos Papageorgiou, Effimia Zacharia, Alexandros Briasoulis, Marietta Charakida & Dimitris Tousoulis. (2016) Celecoxib for the treatment of atherosclerosis. Expert Opinion on Investigational Drugs 25:5, pages 619-633.
Read now
Read now
Leticia Muñoz-Hernando, Jose L Muñoz-Gonzalez, Laura Marqueta-Marques, Carmen Alvarez-Conejo, Álvaro Tejerizo-García, Gregorio Lopez-Gonzalez, Emilia Villegas-Muñoz, Angel Martin-Jimenez & Jesús S Jiménez-López. (2015) Endometriosis: alternative methods of medical treatment. International Journal of Women's Health 7, pages 595-603.
Read now
Read now
Marc Maillard & Michel Burnier. (2006) Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs. Expert Opinion on Drug Safety 5:1, pages 83-94.
Read now
Read now
Articles from other publishers (26)
Sitansu Sekhar Nanda, Dong Kee Yi, Om Prakash Panda, Sridevi Chigurupati, Tapas Kumar Mohapatra & Md. Imran Hossain. (2022) Impact of Indazole Scaffold as Antibacterial and Antifungal Agent. Current Topics in Medicinal Chemistry 22:14, pages 1152-1159.
Crossref
Crossref
Cyril Sobolewski & Noémie Legrand. (2021) Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib. Biomolecules 11:7, pages 1049.
Crossref
Crossref
Hassanein H Hassanein, Doaa E Abdel Rahman, Marwa A Fouad & Rehab F Ahmed. (2021)
Synthesis of new hexahydropyrimido[1,2-
a
]azepine derivatives bearing functionalized aryl and heterocyclic moieties as anti-inflammatory agents
. Future Medicinal Chemistry 13:7, pages 625-641.
Crossref
Crossref
Abida Khan, Anupama Diwan, Hamdy K Thabet & Mohd Imran. (2020) Synthesis of novel N‐substitutedphenyl‐6‐oxo‐3‐phenylpyridazine derivatives as cyclooxygenase‐2 inhibitors. Drug Development Research 81:5, pages 573-584.
Crossref
Crossref
Abida Khan, Anupama Diwan, Hamdy Kh. Thabet, Mohd Imran & Md. Afroz Bakht. (2020) Discovery of Novel Pyridazine-Based Cyclooxygenase-2 Inhibitors with a Promising Gastric Safety Profile. Molecules 25:9, pages 2002.
Crossref
Crossref
Alessio Nocentini & Claudiu T. Supuran. 2019. Carbonic Anhydrases. Carbonic Anhydrases
367
386
.
Daiany P. B. da Silva, Iziara F. Florentino, Dayane M. da Silva, Roberta C. Lino, Carina S. Cardoso, Lorrane K. S. Moreira, Géssica A. Vasconcelos, Daniela C. Vinhal, Anna C. D. Cardoso, Bianca Villavicencio, Hugo Verli, Boniek G. Vaz, Luciano M. Lião, Luiz C. da Cunha, Ricardo Menegatti & Elson A. Costa. (2018) Molecular docking and pharmacological/toxicological assessment of a new compound designed from celecoxib and paracetamol by molecular hybridization. Inflammopharmacology 26:5, pages 1189-1206.
Crossref
Crossref
Priyanka T. Patil, Poojali P. Warekar, Kirti T. Patil, Santosh S. Undare, D. K. Jamale, S. S. Vibhute, N. J. Valekar, Govind B. Kolekar, Madhukar B. Deshmukh & Prashant. V. Anbhule. (2017) A simple and efficient one-pot novel synthesis of pyrazolo[3,4-b][1,8]naphthyridine and pyrazolo[3,4-d]pyrimido[1,2-a]pyrimidine derivatives as anti-inflammatory agents. Research on Chemical Intermediates 44:2, pages 1119-1130.
Crossref
Crossref
Shankar Bhookya, Jalapathi Pochampally, Anil Valeru, Vianala Sunitha, Saikrishna Balabadra, Vijjulatha Manga & Karunakar rao Kudle. (2017) Synthesis of tert-butyl (substituted benzamido)phenylcarbamate derivatives: anti-inflammatory activity and docking studies. Journal of Chemical Biology 10:3, pages 105-115.
Crossref
Crossref
Hyun Tae Kim, Hyunju Cha & Kwang Yeon Hwang. (2016) Structural insight into the inhibition of carbonic anhydrase by the COX-2-selective inhibitor polmacoxib (CG100649). Biochemical and Biophysical Research Communications 478:1, pages 1-6.
Crossref
Crossref
Sherry J. Morgan & Chandikumar S. Elangbam. 2016. Drug Discovery Toxicology. Drug Discovery Toxicology
261
297
.
Kulvinder Kochar Kaur & Gautam Allahbadia. (2016) An Update on Pathophysiology and Medical Management of Endometriosis. Advances in Reproductive Sciences 04:02, pages 53-73.
Crossref
Crossref
Roman V. Frolov & Satpal Singh. (2014) Celecoxib and ion channels: A story of unexpected discoveries. European Journal of Pharmacology 730, pages 61-71.
Crossref
Crossref
Aaron S Kesselheim, Jessica M Franklin, Jerry Avorn & Jon D Duke. (2013) Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs. BMJ Quality & Safety 22:9, pages 727-734.
Crossref
Crossref
Hayam M. Ashour, Omaima G. Shaaban, Ola H. Rizk & Ibrahim M. El-Ashmawy. (2013) Synthesis and biological evaluation of thieno [2′,3′:4,5]pyrimido[1,2-b][1,2,4]triazines and thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines as anti-inflammatory and analgesic agents. European Journal of Medicinal Chemistry 62, pages 341-351.
Crossref
Crossref
Brian R. Berridge, Peter Hoffmann, James R. Turk, Frank Sellke, Gary Gintant, Gerald Hirkaler, Kevin Dreher, A. Eric Schultze, Dana Walker, Nick Edmunds, Wendy Halpern, James Falls, Marty Sanders & Syril D. Pettit. (2013) Integrated and translational nonclinical in vivo cardiovascular risk assessment: Gaps and opportunities. Regulatory Toxicology and Pharmacology 65:1, pages 38-46.
Crossref
Crossref
CARLO A. MARRA, LARRY D. LYND, LINDSEY COLLEY, STEPHANIE S. HARVARD, DIANE LACAILLE, ERIN SCHWENGER, ASLAM H. ANIS & JOHN M. ESDAILE. (2012) Risk of Gastrointestinal Events in Patients with Rheumatoid Arthritis After Withdrawal of Rofecoxib. The Journal of Rheumatology 39:5, pages 910-915.
Crossref
Crossref
RV Frolov, VE Bondarenko & S Singh. (2010) Mechanisms of Kv2.1 channel inhibition by celecoxib - modification of gating and channel block. British Journal of Pharmacology 159:2, pages 405-418.
Crossref
Crossref
K. N. Woodward. 2009. Veterinary Pharmacovigilance. Veterinary Pharmacovigilance
673
689
.
W-C Hwang, A Zhang & M Ramanathan. (2008) Identification of Information Flow-Modulating Drug Targets: A Novel Bridging Paradigm for Drug Discovery. Clinical Pharmacology & Therapeutics 84:5, pages 563-572.
Crossref
Crossref
Gilbert M. Rishton. (2008) Natural Products as a Robust Source of New Drugs and Drug Leads: Past Successes and Present Day Issues. The American Journal of Cardiology 101:10, pages S43-S49.
Crossref
Crossref
J. Conrath. (2007) Traitement médical de l’œdème maculaire. Journal Français d'Ophtalmologie 30:7, pages 748-756.
Crossref
Crossref
Srinivasan Shanmugam, Eung Seok Lee, Tae Cheon Jeong, Chul Soon Yong, Han -Gon Choi, Jong -Soo Woo & Bong Kyu Yoo. (2007) The effect of 1-furan-2-yl-3-pyridine-2-yl-propenone on pharmacokinetic parameters of warfarin. Archives of Pharmacal Research 30:7, pages 898-904.
Crossref
Crossref
Stuart Tugendreich, Cecelia I. Pearson, John Sagartz, Kurt Jarnagin & Kyle Kolaja. (2016) NSAID-Induced Acute Phase Response is Due to Increased Intestinal Permeability and Characterized by Early and Consistent Alterations in Hepatic Gene Expression. Toxicologic Pathology 34:2, pages 168-179.
Crossref
Crossref
Eung-Seok Lee, Byung Chul Park, Seung-Hwan Paek, Yoon-Seok Lee, Arjun Basnet, Da-Qing Jin, Han-Gon Choi, Chul Soon Yong & Jung-Ae Kim. (2006) Potent Analgesic and Anti-inflammatory Activities of 1-Furan-2-yl-3-pyridin-2-yl-propenone with Gastric Ulcer Sparing Effect. Biological and Pharmaceutical Bulletin 29:2, pages 361-364.
Crossref
Crossref
Srinivasan Shanmugam, Eung Seok Lee, Sang Kyu Lee, Tae Won Jeon, Chul Soon Yong & Bong Kyu Yoo. (2006) The Effect of 1-Furan-2-yl-3-pyridine-2-yl-propenone on Pharmacokinetic Parameters of Theophylline. Biological and Pharmaceutical Bulletin 29:6, pages 1282-1285.
Crossref
Crossref